Advertisement
Speaking on the launch of the new Benadryl® variant, Tushar Murdeshwar, Vice President – Marketing, Consumer Division, Johnson & Johnson Ltd., said, “With the launch of the new suppressant Benadryl® DR Dry Cough Active Relief, Benadryl® has further cemented its presence as an expert in the cough category. After the launch of Benadryl CR Congestion Relief variant last year, we have launched Benadryl® DR Dry Cough Active Relief as we felt the need to address the lack of awareness about specialist solutions for different types of cough. As a cough expert, it is our endeavour to constantly provide appropriate solutions to those suffering from any kind of cough.”
Advertisement
Dry and wet cough have different causes and symptoms. A dry or non-productive cough does not release phlegm or mucus while coughing, whereas a wet or productive cough releases phlegm while coughing. Both types of cough have equal incidence but there is a lack of awareness about the need for specific solutions for each. This calls for a clear segmentation in the cough category as the remedy for wet cough cannot work for dry cough and vice versa.
Wet cough requires relief from congestion by expectoration of phlegm whereas a solution for dry cough requires suppression of the cough centre in the brain and a soothing action for the irritated throat. An ideal solution should be non-drowsy and should not cause loss of productive hours, whether at home or at the workplace.
The new product, Benadryl® DR dry cough active relief, is available nationally, across leading pharmacies in pack sizes of 50 ml and 100 ml.
For further information, please contact:
Johnson & Johnson Ltd
Charlotte Rodrigues
Email: [email protected]
Phone: +91 22266646261
